Caspase inhibitors: Prospective therapies for stroke

Neuroscientist

Volumn 19, Issue 2, 2013, Pages 129-136

  Akpan, Nsikan ^a   Troy, Carol M ^a,b  

^a Department of Medicine   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Apoptosis; Caspase; Cerebral ischemia; Edema; Neurodegeneration; Stroke

Indexed keywords

CASPASE INHIBITOR;

APOPTOSIS; CEREBROVASCULAR ACCIDENT; ENZYME ACTIVITY; GLIA; NERVE CELL NECROSIS; NERVE DEGENERATION; PRIORITY JOURNAL; REVIEW;

APOPTOSIS; BRAIN ISCHEMIA; CASPASE INHIBITORS; DRUG DELIVERY SYSTEMS; HUMANS; NEURONS; STROKE;

EID: 84877828780     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858412447875     Document Type: Review

References (47)

1. Akpan N, Serrano-Saiz E, Zacharia BE, Otten ML, Ducruet AF, Snipas SJ, and others. 2011. Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke. J Neurosci 31: 8894-904.
2. Al-Jamal KT, Gherardini L, Bardi G, Nunes A, Guo C, Bussy C, and others. 2011. Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing. Proc Natl Acad Sci U S A 108: 10952-7.
3. American College of Emergency Physicians. 2002. Use of intravenous tPA for the management of acute stroke in the emergency department (Policy Resource and Education Paper, Vol. 2012). Irving (TX): American College of Emergency Physicians.
4. Benchoua A, Guegan C, Couriaud C, Hosseini H, Sampaio N, Morin D, and others. 2001. Specific caspase pathways are activated in the two stages of cerebral infarction. J Neurosci 21: 7127-34.
5. Benkova B, Lozanov V, Ivanov IP, Mitev V. 2009. Evaluation of recombinant caspase specificity by competitive substrates. Anal Biochem 394: 68-74.
6. Boysen G, Marott JL, Gronbaek M, Hassanpour H, Truelsen T. 2009. Long-term survival after stroke: 30 years of followup in a cohort, the Copenhagen City Heart Study. Neuroepidemiology 33: 254-60.
7. Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, and others. 2006. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 296: 2939-46.
8. Centers for Disease Control and Prevention. 2001. Prevalence of disabilities and associated health conditions among adults-United States, 1999. MMWR Morb Mortal Wkly Rep 50: 120-5.
9. Centers for Disease Control and Prevention. 2009. Prevalence and most common causes of disability among adults- United States, 2005. MMWR Morb Mortal Wkly Rep 58: 421-6.
10. Chu Y, Miller JD, Heistad DD. 2007. Gene therapy for stroke: 2006 overview. Curr Hypertens Rep 9: 19-24.
11. Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, and others. 2012. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 69: 29-38.
12. del Zoppo GJ. 2006. Stroke and neurovascular protection. N Engl J Med 354: 553-5.
13. Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, and others. 2009. Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke 40: 2805-11.
14. Dhuria SV, Hanson LR, Frey WH 2nd. 2010. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99: 1654-73.
15. Duan SR, Wang JX, Wang J, Xu R, Zhao JK, Wang DS. 2010. Ischemia induces endoplasmic reticulum stress and cell apoptosis in human brain. Neurosci Lett 475: 132-5.
16. Endres M, Namura S, Shimizu-Sasamata M, Waeber C, Zhang L, Gomez-Isla T, and others. 1998. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J Cereb Blood Flow Metab 18: 238-47.
17. Ferrer I, Planas AM. 2003. Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J Neuropathol Exp Neurol 62: 329-39.
18. Friedlander RM. 2000. Role of caspase 1 in neurologic disease. Arch Neurol. 57: 1273-6.
19. Friedlander RM, Gagliardini V, Hara H, Fink KB, Li W, MacDonald G, and others. 1997. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J Exp Med 185: 933-40.
20. Ginsberg MD. 2008. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55: 363-89.
21. Green DR. 2011. Immunology: a heavyweight knocked out. Nature 479: 48-50.
22. Hara H, Fink K, Endres M, Friedlander RM, Gagliardini V, Yuan J, and others. 1997. Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein. J Cereb Blood Flow Metab 17: 370-5.
23. Harrison DC, Davis RP, Bond BC, Campbell CA, James MF, Parsons AA, and others. 2001. Caspase mRNA expression in a rat model of focal cerebral ischemia. Brain Res Mol Brain Res 89: 133-46.
24. Huesmann GR, Clayton DF. 2006. Dynamic role of postsynaptic caspase-3 and BIRC4 in zebra finch song-response habituation. Neuron 52: 1061-72.
25. Kang SJ, Wang S, Hara H, Peterson EP, Namura S, Amin-Hanjani S, and others. 2000. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J Cell Biol. 149: 613-22.
26. Krajewski S, Krajewska M, Ellerby LM, Welsh K, Xie Z, Deveraux QL, and others. 1999. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci U S A 96: 5752-7.
27. Le DA, Wu Y, Huang Z, Matsushita K, Plesnila N, Augustinack JC, and others. 2002. Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc Natl Acad Sci U S A 99: 15188-93.
28. Lipton P. 1999. Ischemic cell death in brain neurons. Physiol Rev 79: 1431-568.
29. Luthi AU, Martin SJ. 2007. The CASBAH: a searchable database of caspase substrates. Cell Death Differ 14: 641-50.
30. Martin-Villalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, and others. 2001. Therapeutic neutralization of CD95- ligand and TNF attenuates brain damage in stroke. Cell Death Differ 8: 679-86.
31. McStay GP, Salvesen GS, Green DR. 2008. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ 15: 322-31.
32. Niizuma K, Endo H, Nito C, Myer DJ, Kim GS, Chan PH. 2008. The PIDDosome mediates delayed death of hippocampal CA1 neurons after transient global cerebral ischemia in rats. Proc Natl Acad Sci U S A 105: 16368-73.
33. Niizuma K, Yoshioka H, Chen H, Kim GS, Jung JE, Katsu M, and others. 2010. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim Biophys Acta 1802: 92-99.
34. O'Brien, T. (2007), "Caspase Inhibitors in Drug Discovery", in Hengartner, M. (ed.), Apoptosis: Fundamentals, Pathways, Clinical Applications and Role in Disease, The Biomedical & Life Sciences Collection, Henry Stewart Talks Ltd, London (online at http: //hstalks.com/bio).
35. Pop C, Salvesen GS. 2009. Human caspases: activation, specificity, and regulation. J Biol Chem 284: 21777-81.
36. Ribe EM, Serrano-Saiz E, Akpan N, Troy CM. 2008. Mechanisms of neuronal death in disease: defining the models and the players. Biochem J 415: 165-82.
37. Schielke GP, Yang GY, Shivers BD, Betz AL. 1998. Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J Cereb Blood Flow Metab 18: 180-5.
38. Schweizer A, Briand C, Grutter MG. 2003. Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway. J Biol Chem 278: 42441-7.
39. Strbian D, Meretoja A, Putaala J, Kaste M, Tatlisumak T. 2012. Cerebral edema in acute ischemic stroke patients treated with intravenous thrombolysis. Int J Stroke. doi: 10.1111/j.1747-4949.2012.00781.x
40. Stroh C, Schulze-Osthoff K. 1998. Death by a thousand cuts: an ever increasing list of caspase substrates. Cell Death Differ 5: 997-1000.
41. Thorne RG, Pronk GJ, Padmanabhan V, Frey WH 2nd. 2004. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127: 481-96.
42. Velier JJ, Ellison JA, Kikly KK, Spera PA, Barone FC, Feuerstein GZ. 1999. Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat. J Neurosci 19: 5932-41.
43. Venero JL, Burguillos MA, Brundin P, Joseph B. 2011. The executioners sing a new song: killer caspases activate microglia. Cell Death Differ 18: 1679-91.
44. Wang J, Wei Q, Wang CY, Hill WD, Hess DC, Dong Z. 2004. Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 279: 19948-54.
45. Westphal D, Dewson G, Czabotar PE, Kluck RM. 2011. Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta 1813: 521-31.
46. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. 1999. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 96: 13496-500.
47. Yuan J. 2009. Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. Apoptosis 14: 469-77.